Clinical Trials
5 trialsNCT02942758 2024-05-08
AML-ViVA
University Hospital Regensburg
Phase 2 Terminated
NCT02730195 2019-01-09
Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia
Emory University
Phase 2 Terminated
NCT01342770 2017-12-05
Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00951379 2016-04-06
Pioglitazone for Oral Premalignant Lesions
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00923949 2015-09-30
Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated